Comparison of the combination and quinolone therapy in community acquired pneumonia

Soylar O. K., KILINÇ O., ELLİDOKUZ H.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.63, no.3, pp.165-169, 2015 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 63 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.5578/tt.9324
  • Journal Name: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.165-169
  • Keywords: Pneumonia, drug therapy, combination, fluoroquinolones
  • Dokuz Eylül University Affiliated: Yes

Abstract

Introduction: Objective of this study is to compare the difference between the length of hospitalisation, cost of treatment and treatment outcome of patients diagnosed with community acquired pneumonia and treated with beta-lactam-macrolide combination or fluoroquinolone monotherapy, according to 2009 Turkish Thoracic Society (TTS) Guide of Diagnosis and Treatment of Community Acquired Pneumonia in Adults (TTSCAPG).